Here are three things to know.
1. Reports surfaced last month the pharmacy giant is in talks to purchase Aetna for more than $66 billion in cash and stock.
2. CVS Health and Aetna are in advanced stages of negotiating a deal, according to the report. The deal would value Aetna at between $200 and $205 per share.
3. CVS Health’s shares rose 3.9 percent following the news, while Aetna’s stocks increased 1.3 percent, Reuters reports.
More articles on payer issues:
Humana updates severance policy regarding ‘change in control,’ stoking merger speculation
OSF HealthCare, BCBS avoid going out-of-network with new contract
Connecticut lawmakers host hearing to probe Anthem-Hartford HealthCare dispute
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
